Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
May 29, 2020
|
| |
| | | | | Two of Georgia CTSA's leaders head up the NIBIB-funded Atlanta Center Microsystems Engineered Point of Care Technologies (ACME POCT) which has been selected by the NIH, along with their institutions - Emory, Georgia Tech, and Children’s Healthcare of Atlanta - to test and validate some of the most promising technologies for COVID-19 diagnostic testing.
Wilbur Lam, MD, PhD is the Principal Investigator of ACME POCT, clinical hematologist at ... | | | | Read More | | |
|
| |
| | | | | | Please join us via Zoom on Tuesday, June 2nd from 4:00 PM – 5:00 PM to learn more about “Data Collection During COVID-19: Using Remote Methods”. Hear from the experts Keith Campbell, PhD, Nathan Carter, PhD and Melissa Robertson, PhD from UGA to learn and share experiences in collecting data using remote methods such as crowdsourcing and social media through platforms like MTurk, Qualtrics, Reddit, Facebook and more. | | | | Register | | |
|
| |
| | | | The Georgia Clinical & Translational Science Alliance TEAMS (Translational Education and Mentoring for Science) Program is seeking learning community mentors, one-on-one mentors and content experts to participate in the 2020-2021 academic year program. Submit Interest Form by June 1. | | | | Apply Now! | | |
| |
| | | | The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). NIBIB will support the full range of product development including commercialization and product distribution. | | | | Read More | | |
| |
| | | | NIAID recently issued two new funding opportunity announcements (FOAs) as part of our continuing effort to support research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). The two FOAs are ideal for applicants proposing new coronavirus-related research projects. The scope and nature of your proposed research project should guide your decision whether to apply through the R01 or R21 FOA. They feature rolling submission, meaning you can apply as soon as it is ready and NIAID will review it in an expedited fashion. | | | | Read More | | |
| |
| | | | The NIH Common Fund received $30 Million from the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020 to prevent, prepare for, and respond to coronavirus, domestically or internationally. OSC issued this Notice of Special Interest (NOSI), an opportunity for emergency competitive revisions to Common Fund grants and cooperative agreements to support innovative, impactful research on COVID-19 or SARS-CoV-2 in any area of research including behavioral/social science, health disparities, and novel therapeutics that fits within the mission of an emergency response to provide critical expertise, resources or activities. | | | | Read More | | |
| |
| | | | GrantForward is proud to provide free access to a list of funding opportunities in the area of COVID-19. The list of available coronavirus-related funding calls and other support for researchers, non-profit organizations and commercial organizations, with all relevant information, will be updated on a daily basis. | | | | Read More | | |
| |
| | | | NIH and CDC notify PD(s)/PI(s) holding specific types of research grants that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from underrepresented backgrounds, including those from groups that have been shown to be nationally underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Interested applicants should contact Andrew West at awest2@emory.edu. | | | | Read More | | |
| |
| | | | Find the latest opportunities that NCATS is participating in. | | | | Read More | | |
| |
| | | | In addition to dedicating regularly appropriated funds, to date NIH has received emergency funding for COVID-19-related activities in two supplemental bills. To get funding as quickly as possible to the research community, we are using Urgent and Emergency competing revisions and administrative supplements to existing grant awards. | | | | Read More | | |
| |
| | | | For up-to-date NIH COVID-19 information, including: Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and; Funding Opportunities, please visit the link below. | | | | Read More | | |
| |
| | | | Robert Wood Johnson Foundation seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health. | | | | Read More | | |
| |
| | | | The goal of the MP3 Initiative is to facilitate and grow basic and applied infectious disease research across scales at Emory University, from molecules and pathogens within hosts to populations and pandemics, with a focus on COVID-19. An explicit requirement of funding through this program is therefore the subsequent submission of extramural grants. Seed grants are only awarded to teams of researchers from different schools at Emory. Partnerships with the CDC and the Carter Center are strongly encouraged. | | | | Read More | | |
| |
| | | | National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest to highlight the urgent need for research on the 2019 novel coronavirus and the disease it causes. NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. | | | | Read More | | |
| |
| | | | The Fellowships are intended to allow students to seek postdoctoral research opportunities aligned with the student's interest and desire to obtain additional skills and experience that will further their pursuit of careers in complex systems science. The total amount of the JSMF Fellowship is $200,000 USD to be expended in no less than 2 and no more than 3 years. | | | | Read More | | |
| |
| | | | AMAG Pharmaceuticals, Inc. is committed to funding research aimed at reducing the risk of premature birth and preeclampsia in order to improve the health of neonates and infants in the United States through its 2020 Prematurity and Preeclampsia Research Grants Program for a total of $250,000. Consideration will be given to basic or clinical research in maternal, fetal and neonatal/infant health. | | | | Read More | | |
| |
| | | | The Center for Pediatric Cellular Therapies (CPCT) is accepting Late Stage Preclinical/IND Enabling Research and Clinical Trial Launch Grant applications. The principal investigator (PI) must have a faculty appointment in the Emory Department of Pediatrics. Primary, secondary, and adjunct appointments meet this criterion. Staff scientists and fellows may not apply as sole PI; however, they may apply as co-PI on multi-PI applications. | | | | Read More | | |
| |
| | | | Children's and Emory are pleased to announce the availability of pilot grants for several pediatric research centers and junior faculty. These pilots are designed to stimulate new research projects, build new collaborations, and increase extramural funding for pediatric research. | | | | Read More | | |
| |
| | | | The purpose of this Notice of Special Interest is to highlight the list of widely appreciated systematic barriers or translational science problems included in PAR-19-099 and PAR-19-100 to add the following topics of interest: Rural Health, Racial and Ethnic Disparities in Maternal Mortality, Applications for Machine Learning and Artificial Intelligence (AI), Veterans' Health. | | | | Read More | | |
| |
| | | | NIAMS requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently funded individual and/or collaborative research projects more efficiently and/or more effectively. Application budgets are limited to $500,000 direct costs per year. The maximum project period is 5 years. | | | | Read More | | |
| |
| | | | We are pleased to announce the launch of the Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) competition for Emory University investigators. The purpose of this FOA is to solicit applications to participate in a clinical studies program to improve the long-term outcome of adult and pediatric transplant recipients (thoracic organ, abdominal organ, vascular composite tissue, and cellular replacement). | | | | Read More | | |
| |
| | | | The Georgia Clinical & Translational Science Alliance TEAMS (Translational Education and Mentoring for Science) Program is seeking learning community mentors, one-on-one mentors and content experts to participate in the 2020-2021 academic year program. Submit Interest Form by June 1. https://www.surveymonkey.com/r/TSDDV92 | | | | Read More | | |
| |
| | | | Calling All Mentees: The Georgia Clinical & Translational Science Alliance TEAMS (Translational Education and Mentoring in Science) Program is seeking junior-level faculty members, post-docs, or clinical fellows interested in receiving 1:1 and group mentoring. Apply now to be a Fellow! | | | | Apply Now! | | |
| |
| | | | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | | | Volunteer Form | | |
| |
| | | | The COVID-19 Collaboration Platform brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence. COVID-19 Collaboration Platform offers support managing collaborations, including expedited and prioritized help from the Trial Innovation Network and SMART IRB to form multi-site trials; expert statistical advice for aggregated analyses, and free data storage and anonymization through vivli.org. | | | | Read More | | |
| |
| | | | The National Center for Data to Health and NCATS are leading the creation of a national, centralized, secure portal for COVID-19 clinical data. The cloud-based collaborative portal will allow for the development of machine learning and other informatics tools that require a large row-level dataset and will be overseen by a data access committee. This portal will provide additional assets needed to rapidly develop the analytics that clinical centers and physicians need now. | | | | Read More | | |
| |
| | | | NCATS web content on the National COVID Cohort Collaborative (N3C) is now available including links to program resources, related funding opportunities, and frequently asked questions. | | | | Read More | | |
| |
| | | | CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new treatments for neglected diseases. CURE ID is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). | | | | Read More | | |
| |
| | | | We are a community of medical professionals, life scientists and data scientists on a quest to defeat COVID-19. To pitch in, join our discourse! | | | | Read More | | |
| |
| | | | The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world. Learn more about how to request access to resources of the COVID-19 HPC Consortium. | | | | Read More | | |
| |
| | | | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | | | Submit a Request | | |
| |
| | | | Animal Use: Unnecessary Animal Use (PDF) | | | | Read More | | |
| |
| | | | Registration is now open for the SBIR Road Tour stopping at UGA in Athens, GA. National outreach effort connecting entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the SBIR/STTR programs. Opportunity for small businesses, innovators, researchers, entrepreneurs and technology companies to connect directly with SBIR/STTR program managers representing more than a dozen different federal agencies. SBIR/STTR programs provide over $3.7 billion in funding to small businesses each year in a wide variety of technology areas. | | | | Read More & Register | | |
| |
| |  | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | | | Read More | | |
| |
| | | | Please join the Center for Outcomes Research and Public Health (CORPH) via Zoom from 12 PM - 1 PM to discuss claims data for health services research with Assistant Professor Xu Ji and Biostatistician Martha Wetzel. | | | | Read More | | |
| |
| | | | Who can submit an abstract? All child health researchers who are postdocs, fellows and junior faculty with a rank of no higher than assistant professor are invited to submit abstracts as the lead author. Select abstracts will be invited to do oral presentations at the symposium on August 4th, 2020 at the Health Sciences Research Building Auditorium and Café. | | | | Read More | | |
| |
| | | | Please join us Tuesday, June 2nd from 4:00 PM – 5:00 PM to learn more about “Data Collection During COVID-19: Using Remote Methods”. Hear from the experts and share your experiences. | | | | Read more | | |
| |
| | | | Please join us via Zoom from 12:30 PM- 1:30 PM to learn more about how "Myeloid Cells Contribute to Early B-cell Acute Lymphoblastic Leukemia Clearance" with Rae Hunter, MS, MAT. Assistant Professor, David Myers, PhD will also discuss "Timing Matters! How Platelets Use Timing to Enhance Bulk Clot Contraction." | | | | Read More | | |
| |
| | | | Join us on June 3 from 5:30 - 6:30 p.m. for a panel discussion with med-tech funders to learn tips to successfully talk with healthcare focused venture capitalists. Come with questions and gain insight on how best to raise funds in the life sciences. | | | | Register | | |
| |
| | | | During the time you had reserved to participate in the annual conference, we encourage you to participate instead in a special three-hour COVID-19 webinar from 9AM - Noon highlighting COVID-19-related research projects. Special Guest Speaker: Peter J. Hotez, MD, PhD International Expert on Tropical Diseases and Vaccine Development. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
